Background Evidence suggests lungs as the organ most affected by coronavirus disease
2019 (COVID-19). The literature on previous coronavirus infections reports that patients may …

Whilst the entire world is battling the second wave of COVID-19, a substantial proportion of
patients who have suffered from the condition in the past months are reporting symptoms …

Background After the 2002/2003 severe acute respiratory syndrome outbreak, 30% of
survivors exhibited persisting structural pulmonary abnormalities. The long-term pulmonary …

Background Patients with coronavirus disease 2019 (COVID-19) or post-COVID-19 will
probably have a need for rehabilitation during and directly after the hospitalisation. Data on …

Objectives “Long COVID”, a term coined by COVID-19 survivors, describes persistent or new
symptoms in a subset of patients who have recovered from acute illness. Globally, the …

Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-
Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The …

The majority of people infected with SARS-CoV-2 fully recovered within a few weeks.
However, a considerable number of patients of different ages still suffer from long-lasting …

Background There is emerging evidence of long-term sequelae in a considerable proportion
of COVID-19 patients after recovery and the spectrum and severity of such sequelae should …

Coronavirus disease 2019 (COVID-19) is a viral infection which can cause a variety of
respiratory, gastrointestinal, and vascular symptoms. The acute illness phase generally lasts …

Immune-related manifestations are increasingly recognized conditions in patients with
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …